Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janis L Abkowitz

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Blood|March 29, 2022
Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell-extrinsic contributions to erythropoiesisRaymond T Doty, Xing Fan, David J Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cellsMary A Price, Scott S Case, Denise A Carbonaro, et al.
Cell Stem Cell|March 12, 2022
Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell functionAndreea Reilly, J Philip Creamer, Sintra Stewart, et al.
Blood|December 3, 2021
Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndromeCourtnee A Clough, Joseph Pangallo, Martina Sarchi, et al.
Haematologica|September 21, 2014
Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexityMichael Y Zhang, Siobán B Keel, Tom Walsh, et al.
American Journal of Hematology|December 30, 2014
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasmPamela S Becker, Bruno C Medeiros, Anthony S Stein, et al.
Cancers|June 24, 2022
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid NeoplasmsColin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Nature|May 22, 2024
Molecular mechanism of choline and ethanolamine transport in humansKeiken Ri, Tsai-Hsuan Weng, Ainara Claveras Cabezudo, et al.
Blood|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotypeJ Philip Creamer, Suhita Ray, Sintra Stewart, et al.
Blood Advances|June 20, 2023
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AMLAnna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Blood|March 29, 2022
Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell-extrinsic contributions to erythropoiesisRaymond T Doty, Xing Fan, David J Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cellsMary A Price, Scott S Case, Denise A Carbonaro, et al.
Cell Stem Cell|March 12, 2022
Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell functionAndreea Reilly, J Philip Creamer, Sintra Stewart, et al.
Blood|December 3, 2021
Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndromeCourtnee A Clough, Joseph Pangallo, Martina Sarchi, et al.
Haematologica|September 21, 2014
Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexityMichael Y Zhang, Siobán B Keel, Tom Walsh, et al.
American Journal of Hematology|December 30, 2014
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasmPamela S Becker, Bruno C Medeiros, Anthony S Stein, et al.
Cancers|June 24, 2022
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid NeoplasmsColin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Nature|May 22, 2024
Molecular mechanism of choline and ethanolamine transport in humansKeiken Ri, Tsai-Hsuan Weng, Ainara Claveras Cabezudo, et al.
Blood|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotypeJ Philip Creamer, Suhita Ray, Sintra Stewart, et al.
Blood Advances|June 20, 2023
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AMLAnna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Pageof 8